檢索結果 - Brian I. Rini

Refine Results
  1. 1
    New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance

    New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance 由 Brian I. Rini

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma: Current Status and Future Directions

    Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma: Current Status and Future Directions 由 Brian I. Rini

    出版 2007
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Molecular Biomarkers in Advanced Renal Cell Carcinoma

    Molecular Biomarkers in Advanced Renal Cell Carcinoma 由 Pablo Maroto, Brian I. Rini

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Adjuvant therapy in renal cell carcinoma

    Adjuvant therapy in renal cell carcinoma 由 Anita Gul, Brian I. Rini

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Recent Progress in the Management of Advanced Renal Cell Carcinoma

    Recent Progress in the Management of Advanced Renal Cell Carcinoma 由 Jorge A. García, Brian I. Rini

    出版 2007
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Novel agents in renal carcinoma: a reality check

    Novel agents in renal carcinoma: a reality check 由 Yana G. Najjar, Brian I. Rini

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Treatment of renal cell carcinoma: Current status and future directions

    Treatment of renal cell carcinoma: Current status and future directions 由 Pedro C. Barata, Brian I. Rini

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma

    Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma 由 Matthew D. Tucker, Brian I. Rini

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Alternate sunitinib schedules in patients with metastatic renal cell carcinoma

    Alternate sunitinib schedules in patients with metastatic renal cell carcinoma 由 Sarathi Kalra, Brian I. Rini, Eric Jonasch

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting

    Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting 由 David H. Aggen, Charles G. Drake, Brian I. Rini

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Cancer and Leukemia Group B 90206

    Cancer and Leukemia Group B 90206 由 Brian I. Rini, Susan Halabi, John Taylor, Eric J. Small, Richard L. Schilsky

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer afte... 由 Brian I. Rini, Vivian Weinberg, Lawrence Fong, Shauna Conry, Robert M. Hershberg, Eric J. Small

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

    MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy 由 James H. Finke, Jennifer S. Ko, Brian I. Rini, Pat Rayman, Joanna Ireland, Peter A. Cohen

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    A high rate of venous thromboembolism in a multi‐institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

    A high rate of venous thromboembolism in a multi‐institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patie... 由 Apurva A. Desai, Nicholas J. Vogelzang, Brian I. Rini, Rafat Ansari, S Krauß, Walter M. Stadler

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial 由 Brian I. Rini, Joaquim Bellmunt, Jill S. Clancy, Kongming Wang, Andreas G. Niethammer, Hariharan Subramanian, Bernard Escudier

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

    The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer 由 Samuel M. Rubinstein, John A. Steinharter, Jeremy L. Warner, Brian I. Rini, Solange Peters, Toni K. Choueiri

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events 由 Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells

    GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells 由 Gaurisankar Sa, Tanya Das, Christina Moon, Cynthia Hilston, Patricia Rayman, Brian I. Rini, Charles S. Tannenbaum, James H. Finke

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinoma

    Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinoma 由 Brian I. Rini, Bohuslav Melichar, Mayer Fishman, Mototsugu Oya, Yazdi K. Pithavala, Y. Chen, A. Bair, Viktor Grünwald

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    COVID-19 and Cancer: Current Challenges and Perspectives

    COVID-19 and Cancer: Current Challenges and Perspectives 由 Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, Solange Peters, Brian I. Rini, Jeremy L. Warner, Corrie Painter

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: